Engineering cell-based ovarian hormone therapy
(2025) Nature Reviews Bioengineering — Vol. 3, n° 8, p. 620-622 (2025)
Files
1SousaAmorim-NatRevBioeng2025.pdf
Restricted Access - Adobe PDF
- 633.25 KB
Details
- Authors
- Abstract
- Biomimetic endocrine implants bridge tissue engineering and reproductive medicine to offer adaptive and long-lasting hormone therapies for the treatment of ovarian premature insufficiency and menopause. Their clinical translation requires aligned regulatory, ethical and manufacturing pathways.
- Affiliations
Citations
Sousa, M. J., & Andrade Amorim, C. (2025). Engineering cell-based ovarian hormone therapy. Nature Reviews Bioengineering, 3(8), 620-622. https://doi.org/10.1038/s44222-025-00325-2 (Original work published 2025)